LYON, France–(BUSINESS WIRE)—- $MAAT #Cancer–MaaT Pharma Receives FDA Feedback Following Pre-IND Meeting Supporting Continued Development of MaaT034 in Solid Tumors
LYON, France–(BUSINESS WIRE)—- $MAAT #Cancer–MaaT Pharma Receives FDA Feedback Following Pre-IND Meeting Supporting Continued Development of MaaT034 in Solid Tumors